Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Th...Подробнее

Optimizing Therapy in HER2+ Disease with Dr. Reshma MahtaniПодробнее

Optimizing adjuvant treatment in HR+/HER2- early breast cancerПодробнее

Dr. Hope Rugo | San Antonio Breast Cancer Symposium 2022 | General SessionПодробнее

Breast Cancer | Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-N...Подробнее

Dr. Rugo on the Advances in the Treatment of HER2-Positive Breast CancerПодробнее

Dr. Hope Rugo on Trastuzumab Biosimilar in HER2-Positive Breast CancerПодробнее

Optimizing treatment in patients with early-stage HER2-positive breast cancerПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Kevin KalinskyПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Alvaro Moreno-AspitiaПодробнее

Dr. Hope Rugo on Safety of Trastuzumab Biosimilar for HER2+ Breast CancerПодробнее

Asvide: Interview with Prof. Hope S. Rugo: updates in the management of HER2 positive advanced...Подробнее

“Key Breakthroughs in the Field of Breast Cancer Treatment” by Dr. Hope RugoПодробнее

Identifying Patients With High-Risk Early Breast Cancer | Insights from Dr Hope RugoПодробнее

Hope Rugo on Managing Effects From Ovarian Suppression in Patients With Breast CancerПодробнее

Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast CancerПодробнее

Hope Rugo, Oncologist + Shelley Hwang, Surgeon (v2)Подробнее

Optimizing Therapy for HER2-Positive Breast Cancer Study (CompassHER2-pCR)Подробнее

Hope S. Rugo, et al.Подробнее

Breast Cancer: The Next Wave By Dr. Hope RugoПодробнее